Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism Ribosome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Preclinical | DE | 12 Jan 2021 | |
Gram-Negative Bacterial Infections | Preclinical | DE | Squarix GmbhStartup | 12 Jan 2021 |
Gram-Negative Bacterial Infections | Preclinical | DE | 12 Jan 2021 | |
Gram-Negative Bacterial Infections | Preclinical | DE | 12 Jan 2021 | |
Gram-Negative Bacterial Infections | Preclinical | DE | 12 Jan 2021 | |
Gram-Positive Bacterial Infections | Preclinical | DE | 12 Jan 2021 | |
Gram-Positive Bacterial Infections | Preclinical | DE | Squarix GmbhStartup | 12 Jan 2021 |
Gram-Positive Bacterial Infections | Preclinical | DE | 12 Jan 2021 | |
Gram-Positive Bacterial Infections | Preclinical | DE | 12 Jan 2021 | |
Gram-Positive Bacterial Infections | Preclinical | DE | 12 Jan 2021 |